Caroline Etland, Ph.D., RN, CNS, ACHPN
Associate Professor, Hahn School of Nursing, BINR, Univ of San Diego
BIOGRAPHYCaroline Etland, PhD, RN, CNS, ACHPN is a founding member and serves as the President of the Healthcare Surfaces Institute. Working closely with the Executive Director, other members of the board of directors, and the Scientific Advisory Board, she provides expertise in research and healthcare delivery. Dr. Etland is an Associate Faculty member at the University of San Diego Hahn School of Nursing and Health Sciences and the Kaye M. Woltman and Melisa R. McGuire Hospice and Palliative Care Education and Research Fellow. Dr. Etland received her Masters of Science in Nursing from the University of South Alabama at Mobile and her PhD from the University of San Diego. She has extensive experience as an Institutional Review Board member, clinician and leader at Sharp HealthCare.
11:00 am - 12:00 pm
Case Study: Surface Disinfection Incompatibility with Medical Devices Creates Potential Patient Risks
Healthcare facilities are challenged with surface disinfection incompatibility every single day. Chemical and physical incompatibility create microbial reservoirs that make cleaning and disinfection difficult at best and, in some cases, impossible. This issue has not gotten the attention it needs. The Healthcare Surfaces Institute (HSI) and the Association for Healthcare Value Analysis Professionals (AHVAP) collaborated on a recently released case study. These organizations took a deep dive into a costly disinfection incompatibility issue experienced by a large US hospital with a specific medical device used for patient care. This presentation will show what was found during the investigation and suggest ways to address these problems in the future.
This presentation will:
• Explore the current decision-making processes for adopting new medical devices into healthcare environments,
• Review product instructions for use (IFU) and testing data for alignment with the hospital’s cleaning and disinfection process
• Discuss human and fiscal costs associated with unintended consequences of disinfectant and device incompatibility